<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><front><journal-meta><journal-id journal-id-type="nlm-ta">World Allergy Organ J</journal-id><journal-id journal-id-type="iso-abbrev">World Allergy Organ J</journal-id><journal-id journal-id-type="publisher-id">wox</journal-id><journal-title-group><journal-title>The World Allergy Organization Journal</journal-title></journal-title-group><issn pub-type="epub">1939-4551</issn><publisher><publisher-name>World Allergy Organization Journal</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3512609</article-id><article-id pub-id-type="doi">10.1097/01.WOX.0000411926.73449.49</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts of the XXII World Allergy Congress</subject></subj-group><subj-group subj-group-type="heading"><subject>Poster Symposium</subject></subj-group><series-title>Allergic Rhinitis</series-title></article-categories><title-group><article-title>169 The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media in Atopic Children</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nsouli</surname><given-names>Safa</given-names></name><degrees>MD</degrees></contrib></contrib-group><aff>Senior Clinical Research Associate, Asthma and Allergy, Danville Asthma and Allergy Clinic, USA, Danville, CA.</aff><pub-date pub-type="epub"><day>17</day><month>2</month><year>2012</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2012</year></pub-date><volume>5</volume><issue>Suppl 2</issue><issue-title>Abstracts of the XXII World Allergy Congress, 4–8 December, 2012 Cancún, México</issue-title><fpage seq="b">S73</fpage><lpage>S73</lpage><permissions><copyright-statement>Copyright © 2012 by World Allergy Organization</copyright-statement><copyright-year>2012</copyright-year></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="waoj-5-S73a.pdf"></self-uri><abstract><sec><title><offsets xml_i="2099" xml_f="2109" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="2120" xml_f="2405" txt_i="22" txt_f="307">Since chronic inflammation is the histopathologic landmark of otitis media with effusion, clinical observations led us to believe that the use of a Nasal Corticoteroid Ciclesonide may be more effective than an oral antibiotic in the treatment of serous otitis media in atopic children.</offsets></p></sec><sec><title><offsets xml_i="2427" xml_f="2434" txt_i="309" txt_f="316">Methods</offsets></title><p><offsets xml_i="2445" xml_f="3003" txt_i="317" txt_f="875">We studied forty pediatric patients (age 6–11 years) in a randomized open labeled 2-week trial to compare the efficacy of the nasal corticosteroid Ciclesonide 50 mcg/nostril 2 sprays per nostril once a day to an oral antibiotic Amoxicillin/Clavulanate potassium (90 mg/kg/day in 2 divided doses every 12 hours) for the treatment of otitis media with effusion. The efficacy of the treatment options was assessed using pneumatic otoscopy, impedance tympanometry and audiometry to monitor the clinical course of the middle ear effusion in both treatment groups.</offsets></p></sec><sec><title><offsets xml_i="3025" xml_f="3032" txt_i="877" txt_f="884">Results</offsets></title><p><offsets xml_i="3043" xml_f="3149" txt_i="885" txt_f="991">In the group nasal corticosteroid Ciclesonide a resolution of otitis media with effusion occurred at the 8</offsets><sup><offsets xml_i="3154" xml_f="3156" txt_i="991" txt_f="993">th</offsets></sup><offsets xml_i="3162" xml_f="3289" txt_i="993" txt_f="1120"> day. In contrast in the group treated with the oral antibiotic the resolution of otitis media with effusion occurred on the 14</offsets><sup><offsets xml_i="3294" xml_f="3296" txt_i="1120" txt_f="1122">th</offsets></sup><offsets xml_i="3302" xml_f="3307" txt_i="1122" txt_f="1127"> day.</offsets></p></sec><sec><title><offsets xml_i="3329" xml_f="3340" txt_i="1129" txt_f="1140">Conclusions</offsets></title><p><offsets xml_i="3351" xml_f="3604" txt_i="1141" txt_f="1394">In conclusion, the nasal corticosteroid Ciclesonide is more effective than an oral antibiotic. The nasal corticosteroid Ciclesonide may be a safer and shorter therapy given the safety issues with long term use of systemic antibiotics in atopic children.</offsets></p></sec></abstract></article-meta></front></article>